Most Read Articles
Elvira Manzano, 28 Mar 2021
The COVID-19 vaccine AZD1222 by AstraZeneca and the University of Oxford was 79 percent effective overall in preventing symptomatic infections – higher than observed in previous clinical trials of the vaccine – at the interim analysis of a US phase III trial.
3 days ago
Poverty during childhood is associated with accentuated neural-immune signaling, a study has shown.
Stephen Padilla, 6 days ago
Incidence of multiorgan dysfunction is higher among individuals discharged from hospital after COVID-19 than among those in the general population, and this relative risk increase is not confined to the elderly and not uniform across ethnicities, a study has found.
12 Mar 2021
Chronic coronary syndrome (CCS) remains a leading cause of death and disability worldwide. The dual goals of CCS management is to prevent future cardiac events, such as myocardial infarction and death, and to reduce ischaemia and relieve angina symptoms, says Prof Peter Yan, consultant cardiologist and medical director, Peter Yan Cardiology Clinic, Gleneagles Medical Centre, Singapore, during a Servier-sponsored virtual symposium.

Product Highlight - Apidra SoloStar

07 Apr 2021

The Ideal Partner for Basal Insulin1
Now available at an even more affordable price!2

  • An antidiabetic agent used to reduce high blood sugar in patients with diabetes mellitus; it may be given to adults, adolescents and children, 6 years of age and older. It has a rapid onset within 10-20 minutes and a short duration, about 4 hours.3
  • Significantly reduces HbA1c when added with basal insulin for FPG and PPG control
  •  Superior efficacy of insulin glargine + pre-meal insulin glulisine (basal-bolus) vs. premixed insulins4
  • Lesser hypoglycemic events with basal-bolus vs. premixed insulins4
  • Insulin Glulisine 100 units/mL (Apidra SoloStar®) – New SRP Php 435.00 per pen (Savings of Php 383.75 from previous SRP)2

 

REFERENCES:
(1) MR Lankisch et.al. Diabetes, Obesity and Metabolism, 2008: 10:1178-1186.
(2) Based from MDC prices as of June 2,2020.
(3) Apidra Prescribing Info 2008.
(4) Fritsche M. et.al. Diabetes, Obesity and Metabolism, 2010: 12:115-123.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Philippines digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 28 Mar 2021
The COVID-19 vaccine AZD1222 by AstraZeneca and the University of Oxford was 79 percent effective overall in preventing symptomatic infections – higher than observed in previous clinical trials of the vaccine – at the interim analysis of a US phase III trial.
3 days ago
Poverty during childhood is associated with accentuated neural-immune signaling, a study has shown.
Stephen Padilla, 6 days ago
Incidence of multiorgan dysfunction is higher among individuals discharged from hospital after COVID-19 than among those in the general population, and this relative risk increase is not confined to the elderly and not uniform across ethnicities, a study has found.
12 Mar 2021
Chronic coronary syndrome (CCS) remains a leading cause of death and disability worldwide. The dual goals of CCS management is to prevent future cardiac events, such as myocardial infarction and death, and to reduce ischaemia and relieve angina symptoms, says Prof Peter Yan, consultant cardiologist and medical director, Peter Yan Cardiology Clinic, Gleneagles Medical Centre, Singapore, during a Servier-sponsored virtual symposium.